Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis. - Physician's Weekly


Advertisement

Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis.

Jun 26, 2023

ABOUT THE CONTRIBUTORS

  • Brigida Barberio

    Department of Surgery, Oncology and Gastroenterology (DISCOG), Gastroenterology Unit, University of Padova-Azienda Ospedaliera di Padova, Padova, Italy.

    David J Gracie

    Leeds Gastroenterology Institute, St. James’s University Hospital, Leeds, UK; Leeds Institute of Medical Research at St. James’s, University of Leeds, Leeds, UK.

    Christopher J Black

    Leeds Gastroenterology Institute, St. James’s University Hospital, Leeds, UK; Leeds Institute of Medical Research at St. James’s, University of Leeds, Leeds, UK.

    Alexander C Ford

    Leeds Gastroenterology Institute, St. James’s University Hospital, Leeds, UK; Leeds Institute of Medical Research at St. James’s, University of Leeds, Leeds, UK. Electronic address: alexf12399@yahoo.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

Physician’s Weekly Daily Brief

The latest articles and insights from your colleagues in your specialty(ies) of choice.